3.7(top 4%)
Impact Factor
4.2(top 4%)
extended IF
161(top 2%)
H-Index
5.4K
authors
12.7K
papers
327.2K
citations
9.7K
citing journals
99.4K
citing authors

Most Cited Articles of British Journal of Clinical Pharmacology in 2017

TitleYearCitations
Trends in the prescription of novel oral anticoagulants in UK primary care2017160
Microtubule destabilising agents: far more than just antimitotic anticancer drugs2017151
Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial2017136
Defining 'nutraceuticals': neither nutritious nor pharmaceutical2017100
Mediterranean diet, dietary polyphenols and low grade inflammation: results from the MOLI-SANI study201795
The value of patient reporting to the pharmacovigilance system: a systematic review201782
Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis201777
First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis201772
Defining the noninferiority margin and analysing noninferiority: An overview201763
Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses201760
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?201757
A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers201754
Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C201753
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients201753
The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease201753
Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology201751
Population pharmacokinetics and exposure-response of osimertinib in patients with non-small cell lung cancer201751
Understanding and applying pharmacometric modelling and simulation in clinical practice and research201749
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma201749
Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions201748
Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study201746
Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system201746
Factors affecting patient reporting of adverse drug reactions: a systematic review201746
Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates201744
Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1)201744